Nature Communications (Feb 2020)
A central role of IKK2 and TPL2 in JNK activation and viral B-cell transformation
Abstract
IKK2 is the main mediator of the NF-kappaB pathway. Here, the authors demonstrate that LMP1 sustains the survival of Epstein-Barr virus-transformed human B cells and post-transplant lymphoma through IKK2 that induces JNK signaling through TPL2.